SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SINTX Technologies Receives Purchase Orders From Multiple Contract Manufacturing Customers With Aggregate Value Exceeding $3.2M For Production Of Advanced Ceramic Components
Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k
Maxim Group Reinstates Buy on SINTX Technologies, Announces $6 Price Target
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SINTX Technologies Announces $4.5M Private Placement, Issuing 1,882,845 Shares At $2.39 Combined Price With Warrants For 1,882,845 Class A And 1,882,845 Class B Shares Exercisable At $2.14
Why SINTX Technologies Stock Is Trading Lower Today
Sintx Technologies Receives Nasdaq Noncompliance Notice, Gets Time Through July 6 To Regain Compliance
HC Wainwright & Co. Reiterates Buy on SINTX Technologies, Maintains $10 Price Target
SINTX Technologies to Present at the LD Micro Invitational XVI Conference
SINTX Technologies Q1 EPS $(0.70) Misses $(0.66) Estimate, Sales $380.000K Beat $300.000K Estimate
HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
SINTX Releases Corporate Update On Key Milestones, Including First Human Surgical Procedure Using FDA-Approved Foot & Ankle Osteotomy Wedge System
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
SINTX Technologies Completes First-In-Human Surgical Procedure Utilizing FDA-Cleared SINAPTIC Foot & Ankle Osteotomy Wedge System
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
SiNtx Technologies Appoints Ryan Elmore As President
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.